Understanding the causes of sarcopenic obesity in older adults
Official title: Dissecting the Molecular and Cellular Pathophysiology of Sarcopenic Obesity in the Elderly
Run by IRCCS San Raffaele · NCT06320158 · Data updated 2026-11-12
This study looks at how obesity and loss of muscle in older adults are connected and what causes this problem, focusing on people who are having hip surgery and healthy seniors.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 65 Years to 99 Years |
| Sex | All |
| Enrollment | 1108 (estimated) |
| Sponsor | IRCCS San Raffaele Academic / other |
| Locations | 1 site (Milan) |
| Status | Recruiting |
| Started | May 22, 2023 |
| Main results expected | November 30, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | June 18, 2025 |
| Trial ID | NCT06320158 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include elderly individuals aged 65 and older who are candidates for hip surgery or healthy older adults with specific BMI criteria.
✕Probably not a fit
Patients with inflammatory or neurological myopathies, acute heart failure, or active cancer may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the molecular and cellular mechanisms behind sarcopenic obesity, a condition affecting the elderly characterized by the coexistence of obesity and reduced muscle mass. By evaluating patients who are candidates for hip surgery and healthy older adults, the study seeks to uncover how increased fat mass and decreased muscle tissue contribute to this growing public health issue. The research will focus on the interplay between chronic inflammation, hormonal changes, and metabolic alterations in skeletal muscle. Through clinical evaluations, the study hopes to provide insights into the pathophysiology of sarcopenic obesity.
Why it matters
Potential benefit: If successful, this study could lead to better understanding and management strategies for sarcopenic obesity, improving health outcomes for elderly patients.
How similar studies have gone: While the specific molecular mechanisms of sarcopenic obesity are not extensively studied, related research on obesity and sarcopenia has shown promising results in understanding these conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: patients who are candidates for hip surgery * patients who are candidates for hip surgery * age ≥ 65 years * patients able to give consent healthy subjects \- healthy subjects from the geriatric cohort studied in 2016-2017 who at that time were: were overweight (25 ≤ BMI \< 30 kg/m2) or obese (BMI ≥ 30 kg/m2) but had not yet developed sarcopenia Exclusion Criteria: All partecipants * unavailability to participate in the study * inflammatory or neurological myopathies * acute heart failure * active cancer
Where it's running
-
Ospedale San Raffaele
Milan, Italy Recruiting
Study contacts
- Study coordinator: Patrizia Rovere Querini, PhD, MD
- Email: rovere.patrizia@hsr.it
- Phone: +390226436095
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Myokines in metabolic and endocrine diseases linked to sarcopenia
This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.
-
Combined resistance training and high-protein diet to help frailty in sarcopenic obesity women
This trial tests whether adding supervised resistance exercise to a high-protein diet helps frailty in obese, sarcopenic women.
-
How obesity affects daily activities and physical abilities in older adults
This study tests how excess weight in people over 65 impacts daily tasks and physical performance, comparing obese seniors to normal-weight peers.
-
GLP-1 drug effects on muscle and bone during weight loss
It tests whether GLP-1–based weight-loss medication (tirzepatide) plus a lifestyle program changes muscle and bone in adults 18–50 with obesity (BMI 30–40).
-
Eccentric exercise program for older adults with heart failure and muscle loss
This study is testing a 12-week exercise program for older adults with heart failure and muscle loss to see if it can help them get stronger and feel better.
-
Understanding Sarcopenic Obesity in COPD Patients
This study is trying to see how common sarcopenic obesity is in people with COPD and how it affects their breathing, disease severity, and quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.